Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Dilutive issuance
confidence 92%
filed 2026-08-10
Lucas GC Limited entered into an At the Market Offering Agreement on August 7, 2026, authorizing the sale of up to US$25.0 million in Class A ordinary shares through Pacific Century Securities. This is a dilutive equity issuance under an ATM program, which would materially affect existing shareholders through potential dilution. The filing explicitly discloses the sales agreement, placement fee structure (3.5%), and intended use of proceeds, meeting the hallmarks of a material dilutive issuance under Item 3.02 equivalent disclosure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-10
The filing discloses the appointment of Christine Chambers as Chief Financial Officer of MicroVision, Inc., effective August 27, 2026. Item 5.02 explicitly covers this appointment, and the prose centers on her appointment to a principal officer role. While compensatory arrangements are also disclosed, the primary disclosed action is the appointment itself, making exec_appointment the most salient classification. This is material as CFO appointments affect investor assessment of financial leadership and governance.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-08-10
The filing discloses the completion of Aspire Biopharma's acquisition of Dura Driver Control Systems (DCS) for approximately $30 million in cash, with DCS becoming a wholly owned subsidiary. Item 1.01 explicitly covers "Entry into a Material Definitive Agreement" regarding the Purchase Agreement and Closing Agreement, and the press release confirms the acquisition has closed. This represents a material acquisition and change of control event that would significantly affect investor assessment of the registrant's business profile and financial position.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-08-10
HyOrc Corporation entered into Securities Purchase Agreements issuing convertible promissory notes totaling $70,200 principal and an Equity Purchase Agreement with Lambda Ventures for up to $7,500,000 in common stock purchases. The filing explicitly discloses unregistered sales under Section 4(a)(2) and Regulation D, with issuance of 250,000 commitment shares and 750,000 Initial Commitment Shares. This is a classic dilutive private placement raising capital through convertible debt and equity commitments.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-08-10
The filing discloses a material modification to security holder rights (Item 3.03) and a change in control (Item 5.01) triggered by BS1 Fund's conversion of 1,760,000 Class B shares into Class A shares on June 23, 2026. This automatic conversion caused all outstanding Class B shares (which carried 10 votes per share) to convert to Class A shares (1 vote per share), and BS1 Fund's voting power fell below 25%, resulting in loss of majority control. While this involves a technical change-of-control disclosure, the core event is a governance restructuring—the dissipation of a controlling shareholder's voting power through a contractual conversion mechanism—rather than a traditional M&A transaction or executive change.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-08-10
The filing discloses under Item 5.02 that Shinichi Hirano resigned from the Board of Directors of HyOrc Corporation effective May 7, 2026. The resignation was by mutual agreement and explicitly states it was not due to any disagreement regarding operations, policies, accounting, or internal controls. This is a clear executive departure event—a director leaving the board.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-10
Item 2.02
This Item 2.02 disclosure presents Where Food Comes From's financial results for the second quarter and six-month period ended June 30, 2026, including revenue, gross profit, operating income, net income, and diluted EPS comparisons to prior-year periods. The press release (Exhibit 99.1) and conference call transcript (Exhibit 99.2) are incorporated by reference, which is the standard format for earnings releases under Item 2.02. The filing includes detailed financial statements and management commentary on operational performance and strategic initiatives.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-10
The 8-K discloses Item 2.02 (Results of Operations and Financial Condition) with a press release announcing Kopin's Q2 2026 financial results for the quarter ended June 27, 2026. The filing reports total revenues of $12.7 million (51% YoY increase), product revenues of $7.6 million, and net income of $0.9 million per share, representing a significant turnaround from a $5.2 million net loss in Q2 2025. This is a standard earnings release disclosure material to investors.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-08-10
The filing discloses an amendment to a Common Stock Purchase Agreement with White Lion Capital, LLC that provides for the issuance of 2,505,513 shares of Common Stock (the "Commitment Shares") to the Investor, with an additional potential cash payment (True-Up Amount) if the Commitment Fee Price falls below the Minimum Price. Item 3.02 explicitly confirms this is an unregistered sale of equity securities under Section 4(a)(2) and Regulation D, which is a classic dilutive issuance structure. The magnitude of shares and the contingent cash obligation make this material to investors.
View raw filing on EDGAR →
8-K
Governance Other
confidence 72%
filed 2026-08-10
The filing discloses termination of a material advisory services agreement with Kingsway Capital Partners Limited, which is controlled by the Company's Executive Chairman and is a significant stockholder. While Item 1.02 covers termination of material definitive agreements, the core governance significance lies in the related-party nature of the transaction and the unresolved financial impact. The Company cannot estimate the financial consequences and has reserved all rights, suggesting potential litigation or dispute risk with a controlling shareholder's entity.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-08-10
The filing discloses Q2 2026 financial results for the six months ended June 30, 2026, including revenues of $239,000, gross profit of $157,000, operating expenses of $11.6 million, and net loss of $11.3 million ($0.31 per share). Item 2.02 explicitly states the company "issued a press release announcing our financial results for the three and six months ended June 30, 2026," with the press release furnished as Exhibit 99.1. This is a standard earnings release disclosure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-10
The 8-K discloses TEN Holdings' financial results for Q2 2026 (quarter ended June 30, 2026) via a press release filed as Exhibit 99.1 under Item 2.02. The filing reports quarterly revenue of $731,000 (down 34.5% YoY), net loss of $3.0 million, and cash position of $5.8 million following a $7.5 million equity offering. This is a standard earnings release disclosure material to investors assessing the registrant's financial performance and capital position.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-10
The 8-K discloses Harrow's second quarter 2026 financial results under Item 2.02, with a press release (Exhibit 99.1) announcing Q2 revenue of $70.7 million (up 60% sequentially, 11% year-over-year), net loss of $17.3 million, and reiterated full-year 2026 guidance of $350–$365 million in revenue and $80–$100 million in Adjusted EBITDA. The filing includes condensed consolidated financial statements and detailed product-level performance metrics, which are material to investors assessing the registrant's financial condition and operational performance.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-08-10
The filing discloses entry into a material commercial agreement with USTA (Item 1.01) for integration of USTA's proprietary coaching content, curriculum, and American Development Model into ASE's AI-powered coaching platform. The agreement includes trademark licensing, promotional commitments, revenue sharing, and a three-year term with specific termination provisions. This is a strategic partnership involving intellectual property licensing and platform development that materially affects the company's product roadmap and market positioning in the racket sports ecosystem, but does not fit the specific categories of M&A, debt, equity issuance, or other named financial/governance events.
View raw filing on EDGAR →
8-K
Earnings release
confidence 75%
filed 2026-08-10
The filing discloses Q2 2026 financial results under Item 2.02, with revenue of $22.2M (down 51% YoY), gross margin decline from 56.4% to 39.2%, and a net loss of $0.2M versus prior-year net income of $108.6M. While the filing also announces a debt refinance and acquisition of InfoSentience, the primary Item 2.02 disclosure centers on quarterly earnings results. The material revenue decline and margin compression are significant to investors, though the prior-year comparison is distorted by a $96.2M gain from discontinued operations.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-10
EX-99.1
This is a quarterly earnings press release announcing Draganfly's Q2 2026 financial results. The exhibit discloses key financial metrics including revenue of $2,664,237 (26.0% YoY increase), gross profit, comprehensive loss of $11,831,664, cash balance of $131,908,197, and earnings per share of $(0.33) basic and diluted. The document explicitly states "Draganfly Announces Record Quarterly Results" and includes detailed financial tables for the three and six-month periods ended June 30, 2026, along with operational highlights. This is a material event affecting investor assessment of the company's financial performance and position.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-08-10
The filing discloses a material private placement (PIPE) closing on August 10, 2026, in which Smart Dynamics Technology Limited purchased 20 million shares and 160 million warrant shares for $10 million, resulting in a change of control. Item 5.01 explicitly states the Purchaser now owns 67.3% of outstanding shares and would own ~95% upon warrant exercise, constituting a change of control that displaced the former majority holder (Alset Inc./Chan Heng Fai from 82.4% to 27%). This is a material acquisition-like transaction triggering Items 1.01, 3.02, and 5.01.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 98%
filed 2026-08-10
RedCloud Holdings received written notification from Nasdaq on August 10, 2026, that it failed to maintain the minimum market value of listed securities ($35,000,000) required under Nasdaq Listing Rule 5550(b)(2). The company has 180 calendar days until February 8, 2027, to regain compliance or face delisting. This is a classic delisting-risk disclosure under Item 3.01 equivalent, materially affecting investor assessment of the registrant's continued listing status.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-08-10
The 8-K discloses announcement of first quarter fiscal 2027 financial results (ended June 30, 2026) to be released on August 13, 2026, with a management conference call scheduled for August 14, 2026. The press release explicitly states "the first quarter financial results of the 2027 fiscal year will be released on Thursday, August 13, 2026" and management will "discuss the company's financial and operating results." This is a standard earnings release announcement under Item 2.02 and Item 7.01.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-08-10
The filing discloses Netcapital's receipt of a Nasdaq notice (Item 3.01) granting an additional 180-day compliance period until February 1, 2027, to regain compliance with the minimum $1.00 per share bid price requirement. The company failed to regain compliance during the initial 180-day period (ending August 3, 2026) and faces delisting if it does not cure the deficiency by the deadline. This is a material delisting risk disclosure under Item 3.01, distinct from the concurrent amendments to convertible notes (Item 1.01) and unregistered equity issuances (Item 3.02).
View raw filing on EDGAR →
8-K
Going Concern
confidence 92%
filed 2026-08-10
The auditor's report explicitly states "the Company has stated substantial doubt about its ability to continue as a going concern" due to losses from operations. This is a material disclosure required under Item 8.01 (Other Events) that would significantly affect a reasonable investor's assessment of the registrant's viability, despite the company having just completed a $100M+ IPO.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-10
Item 2.02
GoPro issued a press release on August 10, 2026, disclosing its financial results for Q2 2026 ended June 30, 2026. The filing explicitly states "On August 10, 2026, GoPro, Inc. (the "Company") issued a press release to report its financial results for its second quarter ended June 30, 2026" and furnishes the press release as Exhibit 99.1. The exhibit contains detailed quarterly financial statements, revenue metrics ($105 million, down 31% YoY), net loss ($51 million GAAP, $36 million non-GAAP), and management commentary from CEO Nicholas Woodman. This is a standard quarterly earnings release disclosure under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-10
Item 2.02
Quanterix issued a press release on August 10, 2026 announcing Q2 2026 financial results (ended June 30, 2026) with revenue of $32.9 million, GAAP gross margin of 38.5%, adjusted EBITDA loss of $10.0 million, a $26.9 million goodwill impairment, and downward revised 2026 guidance to $142-148 million (from $169-174 million), with cash-flow break-even delayed to 2027.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-10
Item 2.02
This is a clear earnings release for Q2 2026 (quarter ended June 30, 2026). The Item 2.02 disclosure explicitly states that Arq issued a press release related to filing its Form 10-Q and posted an investor presentation of financial results. The press release (Exhibit 99.1) contains detailed quarterly financial results including revenue ($29.9M, up 5%), Adjusted EBITDA ($5.8M, up 59%), gross margin (38.5%, up 520 bps), and net loss metrics, along with full-year 2026 guidance reaffirmation. This is a standard quarterly earnings announcement material to investors.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-10
This is a comprehensive earnings report for Grupo Supervielle's second quarter and first half of 2026, disclosing quarterly financial results including net income (AR$12.8 billion in 2Q26), ROAE metrics (4.4% reported, 12.4% adjusted), asset quality improvements (NPL ratio of 5.5%), and operational metrics. The document explicitly states "Grupo Supervielle Reports 2Q26 Results" and contains detailed financial highlights, profitability analysis, and management commentary typical of a quarterly earnings release.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-10
Item 2.02
Athene Holding Ltd. disclosed its financial results for the second quarter ended June 30, 2026 via a financial supplement made available on August 10, 2026. The Item 2.02 disclosure includes comprehensive quarterly financial statements (condensed consolidated statements of income, balance sheets), key financial metrics (spread related earnings, net investment spread, leverage ratios), and operational data (net flows, asset composition). This is a standard quarterly earnings disclosure material to investors assessing the company's financial performance and condition.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-08-10
Item 7.01
The Item 7.01 disclosure furnishes investor presentation materials for a non-deal roadshow scheduled for August 11, 2026. While the presentation itself covers multiple topics (earnings, acquisition, capital, etc.), the 8-K Item 7.01 filing is a routine Regulation FD disclosure of investor materials. However, the presentation materials disclosed include a material leadership transition: Ted Nissen's retirement effective December 31, 2026, with Vaughan Dozier and Drew Painter promoted to CEO and President respectively, effective January 1, 2027. This executive succession is a governance event material to investors, though the Item 7.01 filing mechanism itself is administrative. The materiality derives from the leadership changes disclosed within the presentation, not from the presentation furnishing itself.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 98%
filed 2026-08-10
Item 8.01
Franklin Resources completed an underwritten public offering of $750 million in 5.500% unsecured notes due 2036 on August 10, 2026, with net proceeds to be used to repay revolving borrowings and for general corporate purposes.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-08-10
EX-99.1
This news release discloses results from an ongoing infill drilling campaign and deep exploration drilling at Blue Moon's Nussir copper-gold-silver project in Norway, currently under construction. The infill program aims to upgrade Indicated Resources to Measured Resources and optimize mine design based on new structural understanding. While the disclosure is primarily operational/geological in nature (drilling results, assay data, resource estimation updates), it is material because it directly affects the economic viability and mine design of a major project under development. The company also announces extensions and new engagements of marketing service providers, which are routine administrative matters. The core substance is the drilling results and their implications for the project's resource base and mine planning.
View raw filing on EDGAR →
6-K
Periodic Quarterly
confidence 95%
filed 2026-08-10
This is YPF's quarterly financial report for 2Q26, presenting consolidated financial statements, segment results, and operational metrics (revenues, EBITDA, CAPEX, production volumes) for the second quarter of 2026. The document is structured as a periodic financial report with detailed KPI tables, segment analysis, and reconciliations—the foreign-issuer equivalent of a 10-Q quarterly report. While it contains operational highlights and forward guidance, the core disclosure is the quarterly financial results themselves, not a discrete event announcement.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-08-10
YPF announced acceptance of an offer from EDENOR to purchase 70% of YPF's shareholding in MetroGAS and 5% in MetroENERGÍA for US$780 million, resulting in YPF's complete divestiture of both entities. This is a material disposition transaction disclosed as a "Material Event" to Argentine regulators, meeting the definition of ma_activity (entry into a material acquisition, disposition, or change of control).
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-08-10
The filing discloses the appointment of Mr. Diego Cesar Santilli as a Director representing Class A Shares, appointed by the Argentine National State (the Class A shareholder) and acknowledged by the Board on August 10, 2026. This is a clear executive/board appointment event. The appointment is material as it represents a change in board composition at a major oil company where the state is a significant shareholder.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-10
Item 2.02
Rapid7 issued a press release announcing financial results for Q2 2026 (fiscal quarter ended June 30, 2026), disclosing revenue of $210.9M, ARR of $824M, operating income, net income, and cash flow metrics, along with forward guidance for Q3 and full-year 2026.
View raw filing on EDGAR →
8-K
Workforce Reduction
confidence 95%
filed 2026-08-10
Item 2.05
Rapid7's board approved a 2026 Restructuring Plan involving a 12% workforce reduction with estimated charges of $10–$11 million primarily for severance and employee transition costs, with the majority of charges expected in Q3–Q4 2026 and execution substantially complete by year-end.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 85%
filed 2026-08-10
Item 8.01
News Corporation discloses ongoing execution of its $1 billion share repurchase program authorized July 15, 2025, with daily buy-back notifications to the ASX showing approximately $412.7 million in cumulative purchases to date across Class A and Class B common stock. Share repurchases constitute a form of capital return to shareholders and are classified as dividend_distribution events under the taxonomy, as they represent a return of capital to security holders alongside the company's intent to "enhance shareholder value."
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 85%
filed 2026-08-10
Item 8.01
News Corporation discloses daily buy-back notifications under its $1 billion repurchase program authorized July 15, 2025, with specific transactions reported to the ASX for Class A and Class B common stock. The Item 8.01 disclosure covers the company's ongoing share repurchase activity, which constitutes a return of capital to shareholders. While the exhibits show daily transaction details (10.5M Class A shares and 62K Class B shares purchased on 10/08/2026 for approximately $270.8M), the core event is the execution of the authorized repurchase program to enhance shareholder value.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-08-10
EX-99.1
Dr. Reddy's has terminated a distribution and promotion agreement with Novartis India Limited effective September 30, 2026, triggered by a change in controlling shareholding of the counterparty. This is a material operational event affecting the company's commercialization of select brands in India, but does not fit the specific categories of M&A activity, material litigation, or other named event types. The termination of a significant distribution arrangement is a strategic business event that would affect investor assessment of the company's revenue streams and market position.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-08-10
Item 3.01
NYSE American initiated a trading halt on June 25, 2026, due to concerns that Northann Corp. filed its 2025 Form 10-K without obtaining auditor approval and consent. The company acknowledges it cannot predict the timing or outcome of the Exchange's review or whether the trading halt will be lifted or further listing proceedings initiated.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 95%
filed 2026-08-10
Item 4.01
The registrant's independent registered public accounting firm resigned effective June 8, 2026, explicitly stating it did not authorize or consent to the inclusion of its audit report in the 2025 10-K, did not complete its audit, and disclaimed any audit report attributed to it.
View raw filing on EDGAR →
8-K
Restatement
confidence 95%
filed 2026-08-10
Item 4.02
The company disclosed non-reliance on the 2025 Form 10-K financial statements for years ended December 31, 2024 and 2025, as the auditor disclaimed its audit report due to incomplete audit procedures and no opinion being formed. Management concluded investors should not rely on those financial statements pending a new audit by a replacement firm.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-08-10
Item 5.02
Two executive departures occurred: Mr. Umesh Patel resigned as an independent director effective April 14, 2026, citing governance failures including unpaid board compensation and lack of D&O insurance; and Mr. Lin Li resigned as Chairman on August 10, 2026 (while retaining his CEO and President roles), following his initial resignation as CEO, President, and Chairman on June 30, 2026 which was partially rescinded.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-10
Item 2.02
Life360 disclosed unaudited financial results for Q2 2026 ended June 30, 2026, reporting record total revenue of $159.0 million (38% YoY growth), subscription revenue of $115.6 million (31% YoY growth), advertising revenue of $22.0 million (315% YoY growth), and Adjusted EBITDA of $31.1 million (53% YoY growth), along with record Paying Circle net additions of 185 thousand and 102.4 million monthly active users.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-10
Item 2.02
Item 2.02 discloses California Resources Corporation's financial and operating results for Q2 2026, including net income of $514 million, adjusted net income of $88 million, adjusted EBITDAX of $338 million, and production of 149 MBoe/d. The press release (Exhibit 99.1) is a standard earnings announcement with quarterly financial highlights, guidance updates, and operational metrics. This is a classic earnings release disclosure under Item 2.02.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-08-10
Item 7.01
Restaurant Brands International announced receipt of an irrevocable exchange notice from 3G Capital to exchange approximately 2.8 million Class B exchangeable limited partnership units, which RBI LP intends to satisfy through a cash repurchase. This is a material capital transaction involving the repurchase of equity units using available cash on hand, reducing 3G Capital's ownership from approximately 24% to 21% of fully diluted shares. While this involves equity repurchase mechanics, it does not fit the specific categories of dilutive_issuance (which concerns new issuances), dividend_distribution (which concerns distributions to holders), or ma_activity (which concerns acquisitions or dispositions of business assets). The event is clearly financial in nature and material to investors assessing the company's capital structure and cash deployment.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-08-10
Item 7.01
RBI LP received an irrevocable exchange notice from 3G Capital to exchange approximately 2.8 million Class B exchangeable limited partnership units, which RBI intends to satisfy through a cash repurchase. This is a material capital transaction involving the repurchase of equity units using available cash on hand, reducing 3G Capital's ownership from approximately 24% to 21% of fully diluted shares. While this involves equity repurchase mechanics, it does not fit the specific categories of dilutive_issuance (which concerns new issuances), dividend_distribution, or ma_activity, making financial_other the most appropriate classification for this capital structure transaction.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-10
Item 2.02
James River Group Holdings reported second quarter 2026 financial results with net income of $4.4 million (up 59% year-over-year), gross written premium of $268.9 million, and tangible common equity per share of $9.01.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-08-10
Item 8.01
The Board of Directors declared a cash dividend of $0.01 per share payable on September 30, 2026 to shareholders of record on September 15, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-10
Item 2.02
This is a clear earnings release disclosing Upwork's Q2 2026 financial results. The Item 2.02 section explicitly states "The Company issued a press release announcing its financial results for the quarter ended June 30, 2026" with the full text attached as Exhibit 99.1. The press release reports Q2 2026 revenue of $191.7 million, GAAP net income of $25.4 million, adjusted EBITDA of $64.1 million, and provides forward guidance for Q3 and full-year 2026. This is a material disclosure affecting investor assessment of the registrant's financial performance.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-08-10
EX-99.1
Innate Pharma entered a strategic partnership with Sobi to license lacutamab, granting Sobi exclusive global commercialization rights upon accelerated approval and potential full development rights following positive Phase 3 results. The transaction includes an upfront payment of USD 75 million plus up to USD 505 million in milestone payments and royalties, constituting a material disposition of development and commercialization rights.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 75%
filed 2026-08-10
EX-99.2
Innate Pharma appointed Markus Jensen as Chief Medical Officer effective September 1, 2026, succeeding Sonia Quaratino. The appointment is material as it involves a named executive officer role critical to clinical and regulatory execution during a pivotal phase of the company's development.
View raw filing on EDGAR →